Record Information |
---|
Version | 2.0 |
---|
Created at | 2006-05-22 15:12:12 UTC |
---|
Updated at | 2020-11-24 22:20:15 UTC |
---|
NP-MRD ID | NP0001030 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Methylimidazoleacetic acid |
---|
Description | Methylimidazoleacetic acid is the main metabolite of histamine. This end product of histamine catabolism is formed by N-methylation in the imidazole ring to methylhistamine by histamine methyltransferase (EC 2.1.1.8) And a subsequent oxidative deamination in the side chain by type B monoamine oxidase (EC 1.4.3.4). Based on studies, it is known that as much as 70 to 80 percent of the histamine metabolized in the body is excreted in the urine as methylimidazoleacetic acid. Thus, urinary methylimidazoleacetic acid being the major and specific histamine metabolite is a clear marker of any changes in histamine metabolism in the body. The urinary excretion of methylimidazoleacetic acid is considered a reliable indicator of histamine turnover rate in the body. The excretion of methylimidazoleacetic acid is higher in men than in women. However, this gender difference is abolished when corrected for creatinine excretion. A possible explanation is that basal histamine turnover is related to body size. There is no significant difference in methylimidazoleacetic acid excretion between smokers and non-smokers when analyzing absolute values (mg/24 h). When using methylimidazoleacetic acid values corrected for creatinine excretion female smokers have significantly higher methylimidazoleacetic acid excretion compared to nonsmokers (PMID: 11411609 , 7130180 , 10350179 , 10202992 ). |
---|
Structure | InChI=1S/C6H8N2O2/c1-8-3-5(7-4-8)2-6(9)10/h3-4H,2H2,1H3,(H,9,10) |
---|
Synonyms | Value | Source |
---|
1,4-Methyl-imidazoleacetic acid | ChEBI | 1-Methylimidazole-4-acetate | ChEBI | Methylimidazoleacetate | ChEBI | tele-Methylimidazoleacetic acid | ChEBI | 1-Methyl-4-imidazoleacetic acid | Kegg | 1,4-Methyl-imidazoleacetate | Generator | 1-Methylimidazole-4-acetic acid | Generator | tele-Methylimidazoleacetate | Generator | 1-Methyl-4-imidazoleacetate | Generator | 1,4-Methylimidazoleacetate | HMDB | 1-Methyl-1H-imidazole-4-acetate | HMDB | 1-Methyl-1H-imidazole-4-acetic acid | HMDB | Methylimidazole acetate | HMDB | MIAA | HMDB | N Tau-methylimidazoleacetic acid | HMDB | Methylimidazoleacetic acid, hydrochloride | HMDB |
|
---|
Chemical Formula | C6H8N2O2 |
---|
Average Mass | 140.1399 Da |
---|
Monoisotopic Mass | 140.05858 Da |
---|
IUPAC Name | 2-(1-methyl-1H-imidazol-4-yl)acetic acid |
---|
Traditional Name | methylimidazoleacetic acid |
---|
CAS Registry Number | 2625-49-2 |
---|
SMILES | CN1C=NC(CC(O)=O)=C1 |
---|
InChI Identifier | InChI=1S/C6H8N2O2/c1-8-3-5(7-4-8)2-6(9)10/h3-4H,2H2,1H3,(H,9,10) |
---|
InChI Key | ZHCKPJGJQOPTLB-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as imidazolyl carboxylic acids and derivatives. These are organic compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an imidazole ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Azoles |
---|
Sub Class | Imidazoles |
---|
Direct Parent | Imidazolyl carboxylic acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Imidazolyl carboxylic acid derivative
- N-substituted imidazole
- Heteroaromatic compound
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Azacycle
- Carbonyl group
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Martens-Lobenhoffer J, Neumann HJ: Determination of 1-methylhistamine and 1-methylimidazoleacetic acid in human urine as a tool for the diagnosis of mastocytosis. J Chromatogr B Biomed Sci Appl. 1999 Jan 8;721(1):135-40. [PubMed:10027644 ]
- Tsuruta Y, Tomida H, Kohashi K, Ohkura Y: Simultaneous determination of imidazoleacetic acid and N tau- and N pi-methylimidazoleacetic acids in human urine by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987 Apr 24;416(1):63-9. [PubMed:3597642 ]
- Khandelwal JK, Hough LB, Pazhenchevsky B, Morrishow AM, Green JP: Presence and measurement of methylimidazoleacetic acids in brain and body fluids. J Biol Chem. 1982 Nov 10;257(21):12815-9. [PubMed:7130180 ]
- Yocum MW, Butterfield JH, Gharib H: Increased plasma calcitonin levels in systemic mast cell disease. Mayo Clin Proc. 1994 Oct;69(10):987-90. [PubMed:7934197 ]
- Prell GD, Khandelwal JK, Burns RS, LeWitt PA, Green JP: Elevated levels of histamine metabolites in cerebrospinal fluid of aging, healthy humans. Compr Gerontol A. 1988 Oct;2(3):114-9. [PubMed:2906817 ]
- Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, Wyatt RJ: Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res. 1995 Jan;14(2):93-104. [PubMed:7711000 ]
- Granerus G, Roupe G, Swanbeck G: Decreased urinary histamine metabolite after successful PUVA treatment of urticaria pigmentosa. J Invest Dermatol. 1981 Jan;76(1):1-3. [PubMed:7462662 ]
- Swahn CG, Sedvall G: Identification and determination of 1-methylimidazole-4-acetic acid in human cerebrospinal fluid by gas chromatography-mass spectrometry. J Neurochem. 1983 Mar;40(3):688-96. [PubMed:6827268 ]
- Johansson AC, Lonnqvist B, Granerus G: The relationship between body size and the urinary excretion of the main histamine metabolite tele-methylimidazoleacetic acid in man. Inflamm Res. 2001 Apr;50 Suppl 2:S70-1. [PubMed:11411609 ]
- Granerus G, Lonnqvist B, Stenstrom M: No sex difference in the urinary excretion of the histamine metabolite methylimidazoleacetic acid (MeImAA) when corrected for creatinine excretion. Inflamm Res. 1999 Apr;48 Suppl 1:S92-3. [PubMed:10350179 ]
- Granerus G, Lonnqvist B, Wass U: Determination of the histamine metabolite tele-methylimidazoleacetic acid and of creatinine in urine by the same HPLC system. Inflamm Res. 1999 Feb;48(2):75-80. [PubMed:10202992 ]
|
---|